Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine vs TVT for Mixed Urinary Incontinence
NCT00523068Phase 4Withdrawn
- Sponsor
- Imperial College London
- Start
- Sep 2007
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolterodine in mixed urinary incontinence (MUI), sponsored by Imperial College London. Planned start Sep 2007; status: withdrawn.
02
Drugs
tolterodine
03
Conditions
mixed urinary incontinence (MUI)
Beyond the preview
Go deeper on NCT00523068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523068.